StockData

Intuitive Surgical vs Smith & Nephew

ISRG and SNN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ISRG and SNN compare

Intuitive Surgical grew revenue faster over the last twelve months (20.5% versus 6.1% for Smith & Nephew).

Intuitive Surgical scores higher on the StockData Score (16 against 6 for Smith & Nephew), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricISRGSNN
Size and price
Market cap$149B–
Share price$430.53$30.51
Change, 1 year−21.7%−6.7%
Change, 5 years30.8%−7.1%
Beta (5Y)0.860.11
Employees17K18K
StockData Score
Total score16 (better)6
Valuation score2 (better)0
Growth score4 (better)1
Performance score4 (better)1
Health score6 (better)4
Dividend score00
Valuation
P/E52.1×–
P/S12.9×–
P/B9.3×–
EV/EBITDA44.3×–
P/FCF41.5×–
PEG1.78–
FCF yield2.4%–
Fair value$331.91–
Margin of safety−29.7%–
Growth
Revenue growth (TTM)20.5% (better)6.1%
Revenue growth, 5Y average18.2% (better)6.2%
Net income growth (TTM)7.7%–
EPS growth (TTM)9.4%52.3% (better)
EPS growth, 5Y average21.8% (better)6.9%
Profitability
Gross margin67.2%68.0% (better)
Operating margin28.4% (better)12.9%
Net margin25.5%–
FCF margin31.1%–
Return on equity18.0%–
Return on invested capital22.6% (better)13.0%
Financial health
Debt / equity0.000.10 (better)
Net debt / EBITDA–−0.31
Interest coverage–5.7×
Current ratio3.33 (better)2.14
Altman Z-score29.56–
Piotroski F-score6–
Dividends and buybacks
Buyback yield3.1%–
Shareholder yield3.1%–
Ownership
Held by institutions88.5%4.2%
Held by insiders0.47%25.1%
Insider net buying, 12 months−$65.4M–
Superinvestors holding2–
Short interest, % of float2.0%–

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.